NIH-funded research R01 grant

Minimal digital mindfulness dose for improving attention and stress response

Official title: Minimally Effective Dosing of Mindfulness Meditation Training

Funded at Carnegie-Mellon University · NIH-11433465 · Data updated 2026-11-12

A study will test how little digital mindfulness training is needed for adults to gain better attention and lower stress responses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCarnegie-Mellon University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 2, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$569,409
NIH project number1R01AT013937-01
Project IDNIH-11433465 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older who report stress and are willing to use a digital mindfulness program.

Less likely to help

Individuals who prefer non-digital mindfulness methods or have contraindications to participation in stress-testing protocols may not benefit.

What this research studies

This project tests different small amounts of digital mindfulness training (0, 1, 3, 7, 10, or 14 sessions) in stressed adults to see which dose helps improve sustained attention and reduce cortisol and blood pressure responses to a social stress test. Participants will use a validated mindfulness app and complete tasks like the SART and TSST to measure attention and stress biology. The findings aim to identify the minimally effective dose that kicks off healthier brain and body responses, guiding future digital mindfulness programs. The study is led by Carnegie Mellon University and involves a large, diverse community sample over several years.

Why it matters

Potential benefit: If successful, people could achieve meaningful stress reduction and better attention with a small, accessible amount of digital mindfulness training.

How similar studies have gone: Preliminary work supports the idea that brief mindfulness training can affect cognitive and stress-related outcomes, but this study will pinpoint the minimal effective dose.

Where this research is happening

  • Carnegie-Mellon University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Creswell, John David — Carnegie-Mellon University
  • Study coordinator: Creswell, John David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.